Australian fast bowler Megan Schutt has received a two-match suspension following a breach of Sports Science and Sports Medicine guidelines concerning prescription medication. Cricket Australia confirmed the disciplinary action, clarifying that the incident occurred out of competition and was entirely unrelated to performance-enhancing substances. I’m sorry for the attention this has caused and appreciate the support I’ve received,” the 33-year-old added. “While this occurred out of competition and was not performance related, I understand that I am responsible for following the Sports Science and Sports Medicine Guidelines, which players receive regular education on, and I should have adhered to these guidelines.
As a result of the suspension, the 33-year-old will be sidelined for two upcoming fixtures: the third and final T20I match against New Zealand at North Sydney Oval on Thursday, October 22, and the WBBL 2026 season opener between the Adelaide Strikers and the Melbourne Stars scheduled for October 31.
In an official statement, Schutt expressed her acceptance of the penalty, stating, “I fully accept the penalty handed down and apologise for failing to meet the standards expected of me.” She further acknowledged her responsibility regarding the guidelines, noting that while the matter was not performance-related, she understood the importance of adhering to the protocols provided to players through regular educational channels.
Cricket Australia committed to providing ongoing support to the pacer while emphasizing the necessity of upholding professional standards for all players. The governing body stated, “We will continue to provide appropriate support to Megan and reinforce the standards and responsibilities expected of everyone representing our game.” Whichever comes first, the ban applies to all international and domestic cricket.
